logo-loader

Xphyto Therapeutics Corp.

Receive alerts
Market:
CSE
Market Cap:
$59.36 m
Price
1.26 CAD
Change
0.00%
52 weeks high
1.42
52 weeks low
0.86

In brief

XPhyto is a science-based cannabis company focused on formulation, clinical validation, and emerging European markets. XPhyto’s 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH, has been granted a unique German cannabis cultivation and extraction licence for scientific purposes by the German Federal Institute for Drugs and Medical Devices (BfArM). XPhyto is pursuing additional opportunities in Germany including cultivation, processing, manufacturing, import, and distribution. 

Deep dive We explore the investor case for growth companies

Snapshot

XPhyto owns German cannabis company Bunker Pflanzenextrakte GmbH which operates from a decommissioned German Air Force command center and nuclear bunker near Munich